324 related articles for article (PubMed ID: 30038027)
21. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery.
Zulkifli M; Spelbring AN; Zhang Y; Soma S; Chen S; Li L; Le T; Shanbhag V; Petris MJ; Chen TY; Ralle M; Barondeau DP; Gohil VM
Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2216722120. PubMed ID: 36848556
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial electron transport is the cellular target of the oncology drug elesclomol.
Blackman RK; Cheung-Ong K; Gebbia M; Proia DA; He S; Kepros J; Jonneaux A; Marchetti P; Kluza J; Rao PE; Wada Y; Giaever G; Nislow C
PLoS One; 2012; 7(1):e29798. PubMed ID: 22253786
[TBL] [Abstract][Full Text] [Related]
23. Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.
Gohil VM
Expert Opin Investig Drugs; 2021 Jan; 30(1):1-4. PubMed ID: 33081534
[No Abstract] [Full Text] [Related]
24. A yeast suppressor screen links Coa4 to the mitochondrial copper delivery pathway for cytochrome c oxidase.
Swaminathan AB; Soma S; Vicary AC; Zulkifli M; Kaur H; Gohil VM
Genetics; 2022 Jul; 221(4):. PubMed ID: 35666203
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.
Zuo X; Dong D; Sun M; Xie H; Kang YJ
PLoS One; 2013; 8(6):e67549. PubMed ID: 23818984
[TBL] [Abstract][Full Text] [Related]
26. Stable COX17 Downregulation Leads to Alterations in Mitochondrial Ultrastructure, Decreased Copper Content and Impaired Cytochrome c Oxidase Biogenesis in HEK293 Cells.
Vanišová M; Burská D; Křížová J; Daňhelovská T; Dosoudilová Ž; Zeman J; Stibůrek L; Hansíková H
Folia Biol (Praha); 2019; 65(4):181-187. PubMed ID: 31903891
[TBL] [Abstract][Full Text] [Related]
27. COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2.
Stroud DA; Maher MJ; Lindau C; Vögtle FN; Frazier AE; Surgenor E; Mountford H; Singh AP; Bonas M; Oeljeklaus S; Warscheid B; Meisinger C; Thorburn DR; Ryan MT
Hum Mol Genet; 2015 Oct; 24(19):5404-15. PubMed ID: 26160915
[TBL] [Abstract][Full Text] [Related]
28. Mutations in COA6 cause cytochrome c oxidase deficiency and neonatal hypertrophic cardiomyopathy.
Baertling F; A M van den Brand M; Hertecant JL; Al-Shamsi A; P van den Heuvel L; Distelmaier F; Mayatepek E; Smeitink JA; Nijtmans LG; Rodenburg RJ
Hum Mutat; 2015 Jan; 36(1):34-8. PubMed ID: 25339201
[TBL] [Abstract][Full Text] [Related]
29. Copper chaperones for cytochrome c oxidase and human disease.
Hamza I; Gitlin JD
J Bioenerg Biomembr; 2002 Oct; 34(5):381-8. PubMed ID: 12539965
[TBL] [Abstract][Full Text] [Related]
30. The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria.
Modica-Napolitano JS; Bharath LP; Hanlon AJ; Hurley LD
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344923
[TBL] [Abstract][Full Text] [Related]
31. The cytosol-synthesized subunit II (Cox2) precursor with the point mutation W56R is correctly processed in yeast mitochondria to rescue cytochrome oxidase.
Cruz-Torres V; Vázquez-Acevedo M; García-Villegas R; Pérez-Martínez X; Mendoza-Hernández G; González-Halphen D
Biochim Biophys Acta; 2012 Dec; 1817(12):2128-39. PubMed ID: 22985601
[TBL] [Abstract][Full Text] [Related]
32. Role of copper in mitochondrial biogenesis via interaction with ATP synthase and cytochrome c oxidase.
Medeiros DM; Jennings D
J Bioenerg Biomembr; 2002 Oct; 34(5):389-95. PubMed ID: 12539966
[TBL] [Abstract][Full Text] [Related]
33. The Involvement of Cytochrome c Oxidase in Mitochondrial Fusion in Primary Cultures of Neonatal Rat Cardiomyocytes.
Yin W; Li R; Feng X; James Kang Y
Cardiovasc Toxicol; 2018 Aug; 18(4):365-373. PubMed ID: 29396798
[TBL] [Abstract][Full Text] [Related]
34. Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development.
Takahashi Y; Kako K; Kashiwabara S; Takehara A; Inada Y; Arai H; Nakada K; Kodama H; Hayashi J; Baba T; Munekata E
Mol Cell Biol; 2002 Nov; 22(21):7614-21. PubMed ID: 12370308
[TBL] [Abstract][Full Text] [Related]
35. Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery.
Garza NM; Zulkifli M; Gohil VM
J Biol Chem; 2022 Jul; 298(7):102139. PubMed ID: 35714767
[TBL] [Abstract][Full Text] [Related]
36. Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart.
Zeng H; Saari JT; Johnson WT
J Nutr; 2007 Jan; 137(1):14-8. PubMed ID: 17182794
[TBL] [Abstract][Full Text] [Related]
37. Cardiac nuclear encoded cytochrome c oxidase subunits are decreased with copper restriction but not iron restriction: gene expression, protein synthesis and heat shock protein aspects.
Medeiros DM; Shiry L; Samelman T
Comp Biochem Physiol A Physiol; 1997 May; 117(1):77-87. PubMed ID: 9185337
[TBL] [Abstract][Full Text] [Related]
38. FDX1 Is Required for the Biogenesis of Mitochondrial Cytochrome c Oxidase in Mammalian Cells.
Zulkifli M; Okonkwo AU; Gohil VM
J Mol Biol; 2023 Dec; 435(23):168317. PubMed ID: 37858707
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial matrix copper complex used in metallation of cytochrome oxidase and superoxide dismutase.
Cobine PA; Pierrel F; Bestwick ML; Winge DR
J Biol Chem; 2006 Dec; 281(48):36552-9. PubMed ID: 17008312
[TBL] [Abstract][Full Text] [Related]
40. Higd1a improves respiratory function in the models of mitochondrial disorder.
Nagao T; Shintani Y; Hayashi T; Kioka H; Kato H; Nishida Y; Yamazaki S; Tsukamoto O; Yashirogi S; Yazawa I; Asano Y; Shinzawa-Itoh K; Imamura H; Suzuki T; Suzuki T; Goto YI; Takashima S
FASEB J; 2020 Jan; 34(1):1859-1871. PubMed ID: 31914602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
